Harry Bartelink

37.5k citations

270 papers · 20.5k indexed · 10 hit papers · h-index 74

Impact in

Cancer Research top 0.05%
- Breast Cancer Treatment Studies
Radiation top 0.05%
- Advanced Radiotherapy Techniques

Papers in

Cancer Research 124
- Breast Cancer Treatment Studies 111
Radiation 48
- Advanced Radiotherapy Techniques 48

Co-authors: M. Piérart Marcel Verheij Jean-Claude Horiot Philip Poortmans Alain Fourquet Laurence Collette H. Struikmans Berthe M.P. Aleman
Journals: Radiotherapy and Oncology (67 papers)International Journal of Radiation Oncology*Biology*Physics (47 papers)European Journal of Cancer (31 papers)Journal of Clinical Oncology (14 papers)Clinical Cancer Research (5 papers)
Partner nations: Netherlands France Belgium

In The Last Decade

Harry Bartelink

266 papers receiving 19.9k citations

Hit Papers

10 papers align trajectories log scale

Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial 2012 · 377 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 The Lancet Oncology
2007 Journal of Clinical Oncology
2007 JNCI Journal of the National Cancer Institute
2006 Blood
2005 Proceedings of the National Academy of Sciences
2003 Journal of Clinical Oncology
2001 New England Journal of Medicine
1998 European Journal of Cancer
1997 Journal of Clinical Oncology
1992 New England Journal of Medicine

Peers

Countries citing papers authored by Harry Bartelink

Since Specialization

Citations

This map shows the geographic impact of Harry Bartelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Bartelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Bartelink more than expected).

Fields of papers citing papers by Harry Bartelink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Bartelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Bartelink. The network helps show where Harry Bartelink may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Harry Bartelink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Harry Bartelink Line = papers co-authored together Harry Bartelink links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE) Radiotherapy and Oncology ·Ryouta ABE, J. Giralt, Yungan Tao, Sergi Benavente, Nataliya Ageshkina, Frank Hoebers, Ann Hoeben, Chris H.J. Terhaard, G. Wilhelm Nebe, Signe Friesland, Roel J.H.M. Steenbakkers, Lisa Tans, Jolien Heukelom, Chunmei Shi, Simon van Kranen, Harry Bartelink, C. Rasch, Jan‐Jakob Sonke, Olga Hamming‐Vrieze	2024	5
2	A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients Radiotherapy and Oncology ·Sophie C.J. Bosma, Marlous Hoogstraat, Erik van Werkhoven, Michiel de Maaker, Femke van der Leij, Paula H.M. Elkhuizen, Alain Fourquet, Philip Poortmans, Liesbeth Boersma, Harry Bartelink, Marc J. van de Vijver	2020	6
3	Drug Sensitivity Prediction Models Reveal a Link between DNA Repair Defects and Poor Prognosis in HNSCC Cancer Research ·Paul Essers, Xie Mu-ju, Caroline V.M. Verhagen, Sumangala P. Rao, Reinout H. de Roest, C. René Leemans, Ruud H. Brakenhoff, Michiel W. M. van den Brekel, Harry Bartelink, Marcel Verheij, Conchita Vens	2019	13
4	Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer Clinical Cancer Research ·Corey Speers, Shuang Zhao, Meilan Liu, Harry Bartelink, Lori J. Pierce, Felix Y. Feng	2015	114
5	Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping The Breast Journal ·Gordon F. Schwartz, Harry Bartelink, Harold J. Burstein, Blake Cady, Luigi Cataliotti, Ian S. Fentiman, Roland Holland, Kevin S. Hughes, Shahla Masood, Beryl McCormick, Juan Palazzo, Peter Pressman, Jorge S. Reis‐Filho, Lajos Pusztai, Emiel J. Rutgers, Andrew D. Seidman, Lawrence J. Solin, Joseph A. Sparano	2012	11
6	Search for a Gene Expression Signature of Breast Cancer Local Recurrence in Young Women Clinical Cancer Research ·Nicolas Servant, Marc A. Bollet, Hans Halfwerk, Kevin Bleakley, Bas Kreike, Laurent Jacob, Daoud Sie, Ron Kerkhoven, Philippe Hupé, 良太郎藤谷, Alain Fourquet, Harry Bartelink, Emmanuel Barillot, Brigitte Sigal‐Zafrani, Marc J. van de Vijver	2012	55
7	Local Recurrence after Breast-Conserving Therapy in Relation to Gene Expression Patterns in a Large Series of Patients Clinical Cancer Research ·Bas Kreike, Hans Halfwerk, Nicola J. Armstrong, Peter Bult, John A. Foekens, Sanne C. Veltkamp, Dimitry S.A. Nuyten, Harry Bartelink, Marc J. van de Vijver	2009	68
8	The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial International Journal of Radiation OncologyBiologyPhysics ·Helen Jones, Ninja Antonini, Bonnie L. MacDougall, Alain Fourquet, W.J. Hoogenraad, W. Van den Bogaert, J.J. Jager, P. Poortmans, H. Struikmans, Harry Bartelink	2007	6
9	Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy British Journal of Cancer ·Edwin P. M. Jansen, Henk Boot, R. Dubbelman, Harry Bartelink, Annemieke Cats, Marcel Verheij	2007	22
10	Quality assurance in breast cancer: EORTC experiences in the phase III trial on irradiation of the internal mammary nodes European Journal of Cancer ·E. Musat, Philip Poortmans, Walter Van den Bogaert, H. Struikmans, Alain Fourquet, Harry Bartelink, Carine Kirkove, Volker Budach, M. Piérart, Laurence Collette	2007	24
11	A Phase I–II Study of Postoperative Capecitabine-Based Chemoradiotherapy in Gastric Cancer International Journal of Radiation OncologyBiologyPhysics ·Edwin P. M. Jansen, Henk Boot, Mark Saunders, Tom Crosby, R. Dubbelman, Harry Bartelink, Marcel Verheij, Annemieke Cats	2007	31
12	Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving Therapy Clinical Cancer Research ·Bas Kreike, Hans Halfwerk, Petra Kristel, Annuska M. Glas, Hans Peterse, Harry Bartelink, Marc J. van de Vijver	2006	44
13	Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival Proceedings of the National Academy of Sciences ·Howard Y. Chang, Dimitry S.A. Nuyten, Julie B. Sneddon, Trevor Hastie, Robert Tibshirani, Thérese Sørlie, Hongyue Dai, Yudong D. He, Laura J. van’t Veer, Harry Bartelink, Matt van de Rijn, Patrick O. Brown, Marc J. van de Vijver Hit paper breakdown →	2005	733
14	Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer International Journal of Radiation OncologyBiologyPhysics ·Floris J. Pos, Simon Horenblas, Joos V. Lebesque, L. Moonen, Christoph Schneider, Peter Sminia, Harry Bartelink	2004	17
15	Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement International Journal of Radiation OncologyBiologyPhysics ·Xavier Artignan, Monique H.P. Smitsmans, A D Fochini, David A. Jaffray, F.F.O. Junior, Harry Bartelink	2004	93
16	High Response Rates and Lasting Remissions After Low-Dose Involved Field Radiotherapy in Indolent Lymphomas Journal of Clinical Oncology ·Rick L. Haas, P Poortmans, Daphne de Jong, Berthe M.P. Aleman, L. Dewit, Marcel Verheij, A.A.M. Hart, Marinus H. J. van Oers, M. van der Hulst, Johanna Andreina Díaz Valencia, Harry Bartelink	2003	119
17	Does the combination of radiotherapy and debulking surgery favor survival in paranasal sinus carcinoma? International Journal of Radiation OncologyBiologyPhysics ·Edwin P. M. Jansen, Ronald B. Keus, Frans J. M. Hilgers, Rick L. Haas, I. Bing Tan, Harry Bartelink	2000	91
18	Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment Radiotherapy and Oncology ·L. Moonen, H. van der Voet, M Tsukane, Augustinus A. M. Hart, Simon Horenblas, Harry Bartelink	1998	28
19	Chemotherapy in locally advanced head and neck cancer: a critical reappraisal Cancer Treatment Reviews ·Jacek Jassem, Harry Bartelink	1995	8
20	Radiosensitization by Cisplatin of RIF1 Tumour Cells in Vitro International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine ·Adrian C. Begg, Gareth W. Phillips, L. Dewit, Harry Bartelink	1986	76

About Harry Bartelink

Harry Bartelink is a scholar working on Cancer Research, Radiation, Otorhinolaryngology, Pathology and Forensic Medicine and Oncology, having authored 270 papers that have together received 20.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (111 papers), Breast Lesions and Carcinomas (58 papers), Advanced Radiotherapy Techniques (48 papers), Head and Neck Cancer Studies (24 papers), Lymphoma Diagnosis and Treatment (22 papers), Breast Implant and Reconstruction (22 papers), Lung Cancer Treatments and Mutations (20 papers) and Effects of Radiation Exposure (16 papers). The work is most often cited by research in Cancer Research (9.1k citations), Radiation (3.8k citations), Otorhinolaryngology (1.3k citations), Pathology and Forensic Medicine (5.2k citations) and Oncology (7.1k citations). Harry Bartelink has collaborated with scholars based in Netherlands, France and Belgium. Frequent co-authors include M. Piérart, Marcel Verheij, Jean-Claude Horiot, Philip Poortmans, Alain Fourquet, Laurence Collette, H. Struikmans, Berthe M.P. Aleman, Flora E. van Leeuwen and Walter Van den Bogaert. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Journal of Clinical Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact